Stock Track | Alphatec Plunges 20.04% in Pre-Market on Q1 Revenue Miss, $34M Loss, and Analyst Downgrades

Stock Track

May 06

Alphatec Holdings (NASDAQ: ATEC) experienced a sharp pre-market decline of 20.04% on Wednesday, following the release of its first-quarter 2026 financial results and subsequent analyst price target cuts.

The medical device company reported quarterly revenue of $192.108 million, which fell short of the analyst consensus estimate of $197.345 million. Despite showing a 13.55% year-over-year increase, the revenue miss disappointed investors. The company also posted a net loss of $34 million for the quarter, with a basic loss per share of $0.22.

Adding to the negative sentiment, major financial institutions revised their outlook on the stock. JP Morgan slashed its price target on Alphatec to $16 from $24, while Piper Sandler cut its target to $14 from $25. Concurrently, the company announced a debt refinancing initiative involving a new $300 million credit facility, which management stated is expected to reduce annual interest expense by over $6 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1169901942"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169901942\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169901942?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 16:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169901942","market":"sg","top_or_hot":-1,"title":"Stock Track | Alphatec Plunges 20.04% in Pre-Market on Q1 Revenue Miss, $34M Loss, and Analyst Downgrades","media":"Stock Track","content":"<p>Alphatec Holdings (NASDAQ: ATEC) experienced a sharp pre-market decline of 20.04% on Wednesday, following the release of its first-quarter 2026 financial results and subsequent analyst price target cuts.</p><p>The medical device company reported quarterly revenue of $192.108 million, which fell short of the analyst consensus estimate of $197.345 million. Despite showing a 13.55% year-over-year increase, the revenue miss disappointed investors. The company also posted a net loss of $34 million for the quarter, with a basic loss per share of $0.22.</p><p>Adding to the negative sentiment, major financial institutions revised their outlook on the stock. JP Morgan slashed its price target on Alphatec to $16 from $24, while Piper Sandler cut its target to $14 from $25. Concurrently, the company announced a debt refinancing initiative involving a new $300 million credit facility, which management stated is expected to reduce annual interest expense by over $6 million.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Alphatec Plunges 20.04% in Pre-Market on Q1 Revenue Miss, $34M Loss, and Analyst Downgrades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Alphatec Plunges 20.04% in Pre-Market on Q1 Revenue Miss, $34M Loss, and Analyst Downgrades\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-06 16:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alphatec Holdings (NASDAQ: ATEC) experienced a sharp pre-market decline of 20.04% on Wednesday, following the release of its first-quarter 2026 financial results and subsequent analyst price target cuts.</p><p>The medical device company reported quarterly revenue of $192.108 million, which fell short of the analyst consensus estimate of $197.345 million. Despite showing a 13.55% year-over-year increase, the revenue miss disappointed investors. The company also posted a net loss of $34 million for the quarter, with a basic loss per share of $0.22.</p><p>Adding to the negative sentiment, major financial institutions revised their outlook on the stock. JP Morgan slashed its price target on Alphatec to $16 from $24, while Piper Sandler cut its target to $14 from $25. Concurrently, the company announced a debt refinancing initiative involving a new $300 million credit facility, which management stated is expected to reduce annual interest expense by over $6 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATEC","symbol_name":"阿尔法泰克","start_time":0,"source_url":"","article_id":"1169901942","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169901942","pubTimestamp":1778057741,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Alphatec Holdings (NASDAQ: ATEC) experienced a sharp pre-market decline of 20.04% on Wednesday, following the release of its first-quarter 2026 financial results and subsequent analyst price target...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ATEC":"阿尔法泰克"},"translate_title":"个股追踪|Alphatec盘前暴跌20.04%，因Q1营收未达预期、亏损3400万美元、分析师下调评级","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATEC":1},"content_text":"Alphatec Holdings (NASDAQ: ATEC) experienced a sharp pre-market decline of 20.04% on Wednesday, following the release of its first-quarter 2026 financial results and subsequent analyst price target cuts.The medical device company reported quarterly revenue of $192.108 million, which fell short of the analyst consensus estimate of $197.345 million. Despite showing a 13.55% year-over-year increase, the revenue miss disappointed investors. The company also posted a net loss of $34 million for the quarter, with a basic loss per share of $0.22.Adding to the negative sentiment, major financial institutions revised their outlook on the stock. JP Morgan slashed its price target on Alphatec to $16 from $24, while Piper Sandler cut its target to $14 from $25. Concurrently, the company announced a debt refinancing initiative involving a new $300 million credit facility, which management stated is expected to reduce annual interest expense by over $6 million.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}